HomeTNXP • NASDAQ
add
Tonix Pharmaceuticals Holding Corp
Previous close
$31.21
Day range
$28.51 - $31.28
Year range
$6.76 - $130.00
Market cap
250.79M USD
Avg Volume
1.78M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.00M | -9.51% |
Operating expense | 27.02M | 57.10% |
Net income | -28.27M | 64.11% |
Net profit margin | -1.42K | 60.34% |
Earnings per share | -4.00 | 99.14% |
EBITDA | -27.81M | -59.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 125.33M | 2,915.66% |
Total assets | 187.36M | 166.49% |
Total liabilities | 19.36M | -31.36% |
Total equity | 168.00M | — |
Shares outstanding | 8.77M | — |
Price to book | 1.40 | — |
Return on assets | -37.21% | — |
Return on capital | -40.49% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -28.27M | 64.11% |
Cash from operations | -14.83M | -49.54% |
Cash from investing | -2.54M | — |
Cash from financing | 10.99M | 56.48% |
Net change in cash | -6.38M | -120.64% |
Free cash flow | -9.72M | -74.89% |
About
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Founded
2007
Headquarters
Website
Employees
81
